Should Colchicine Become Standard Therapy for CAD?

Collaborative CME and Research Network

P. Ridker

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

Time to Retire Aspirin?

Top Ten Topics in Clinical Cardiology 2021

R. Mehran

CRT 2025 Insights: Artificial Intelligence Based System for Identify…

CRT 2025 Insights

Y. Feld

TCT 2024 Insights: Antiplatelet Therapy and All-Cause Mortality Afte…

TCT 2024 Insights

M. Zimarino

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

Emotional Toll of Complications

The Christ Hospital Heart & Vascular Institute

W. Lombardi

ESC 2024 Insights: State-of-the-Art Lecture on Calcium Modification:…

ESC 2024 Insights

A. Kini

CT FFR Is Already the Gold Standard for Ischemia Evaluation. Here Is…

Controversies in Interventional Cardiovascular Therapies - CICT 2024

K. Al-Azizi

ACC/AHA Guideline for Perioperative Cardiovascular Management for No…

MonteHeart Imaging & Clinical Lectures

P. Parwani

Catheters, Guidewires, and Other Devices to Achieve Technical Succes…

Jaikirshan Khatri

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern

Co-Registration: Do We Really Need It? - 2025 Update

ARCH Advanced Revascularization Symposium

P. Thakker

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

Intravenous ADP Antagonist: Use in High-Risk PCI and ACS

San Diego Cardiovascular Interventions Symposium 2024

E. Mahmud